Orexigen Therapeutics (OREX) Tops Q3 EPS by 22c
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Research and development: 5.25M
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Research and development: 5.25M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Orexigen Therapeutics (NASDAQ: OREX) reported Q3 EPS of $0.09, $0.22 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $30.9 million versus the consensus estimate of $8.93 million.
For earnings history and earnings-related data on Orexigen Therapeutics (OREX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- NextEra Energy Partners (NEP) Tops Q1 EPS by 50c
- Dime Community Bancshares (DCOM) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
